Gingival crevicular fluid galectin-3 and interleukin-1 beta levels in stage 3 periodontitis with grade B and C
- PMID: 37017753
- DOI: 10.1007/s00784-023-04991-7
Gingival crevicular fluid galectin-3 and interleukin-1 beta levels in stage 3 periodontitis with grade B and C
Abstract
Objectives: This study aims to evaluate GCF Galectin-3 and Interleukin-1 beta (IL-β) levels in different grades (B and C) of stage 3 periodontitis, concurrently, and also to investigate their discriminative efficiencies in periodontal diseases.
Materials and methods: A total of 80 systemically healthy and non-smoker individuals, 20 stage 3 grade C (S3GC) periodontitis 20 stage 3 grade B (S3GB) periodontitis, 20 gingivitis, and 20 periodontally healthy were enrolled. Clinical periodontal parameters were recorded and GCF Galectin-3 and IL-1β total amounts were measured by ELISA. Receiver operating characteristics curve was used for estimating the area under the curve (AUC).
Results: Galectin-3 and IL-1β were detected in all participants. Both periodontitis groups had significantly higher GCF Galectin-3 total amounts than periodontally healthy controls (p <0.05). S3GC periodontitis group had also significantly higher GCF Galectin-3 levels than gingivitis group (p <0.05). GCF IL-1β levels in periodontitis groups were higher than gingivitis and periodontally healthy groups (p <0.05). Galectin-3 exhibited an AUC value of 0.89 with 95% sensitivity to discriminate S3GC periodontitis from periodontal health, an AUC value of 0.87 with 80% sensitivity to discriminate S3GC periodontitis versus gingivitis, while an AUC value of 0.85 with 95% sensitivity to discriminate S3GB periodontitis from healthy controls.
Conclusions: GCF Galectin-3 levels are involved in the pathogenesis of periodontal diseases. Galectin-3 showed excellent diagnostic performances to discriminate S3GB and S3GC periodontitis from periodontal health and gingivitis.
Clinical relevance: The present findings suggest that GCF Galectin-3 levels may be useful in the diagnosis of the periodontal diseases.
Keywords: Cytokine; Gingival crevicular fluid; Inflammation; Periodontitis.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Feres M, Retamal-Valdes B, Gonçalves C, Figueiredo LC, Teles F (2021) Did Omics change periodontal therapy? Periodontol 2000 85:182–209. https://doi.org/10.1111/prd.12358 - DOI - PubMed
-
- Joseph S, Curtis MA (2021) Microbial transitions from health to disease. Periodontol 2000 86:201–209. https://doi.org/10.1111/prd.12377 - DOI - PubMed
-
- Sedghi L, DiMassa V, Harrington A, Lynch SV, Kapila YL (2021) The oral microbiome: role of key organisms and complex networks in oral health and disease. Periodontol 2000 87:107–131. https://doi.org/10.1111/prd.12393 - DOI - PubMed - PMC
-
- Çekici A, Kantarcı A, Hastürk H, Van Dyke TE (2014) Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 64:57–80. https://doi.org/10.1111/prd.12002 - DOI - PubMed - PMC
-
- Belibasakis GN, Belstrøm D, Eick S, Gursoy UK, Johansson A, Könönen E (2023) Periodontal microbiology and microbial etiology of periodontal diseases: historical concepts and contemporary perspectives. Periodontol 2000. https://doi.org/10.1111/prd.12473
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
